Tipiracil Hydrochloride is a thymidine phosphorylase inhibitor utilized in combination therapy for the treatment of metastatic colorectal cancer, primarily by inhibiting the degradation of trifluridine… Read more
Tipiracil Hydrochloride is a thymidine phosphorylase inhibitor utilized in combination therapy for the treatment of metastatic colorectal cancer, primarily by inhibiting the degradation of trifluridine to enhance its bioavailability and therapeutic efficacy. This category provides high-quality reference standards of Tipiracil Hydrochloride, including its pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope labelled compounds. Analytical laboratories rely on these reference materials for essential tasks such as impurity profiling, method validation, and rigorous quality control throughout the pharmaceutical development lifecycle. By facilitating the accurate identification and quantification of related substances, these standards ensure compliance with regulatory requirements and support the consistent monitoring of drug purity and stability. Researchers and chemists can utilize these products to support precise analytical testing protocols, ensuring the reliability of data generated during the production and evaluation of this therapeutic agent.